Result card

  • LEG4: Does the use of Genetic Tests for breast cancer produce some additional (i.e. diagnostically or therapeutically irrelevant) information on the patient?
English
No adaptation help available for this domain

Does the use of Genetic Tests for breast cancer produce some additional (i.e. diagnostically or therapeutically irrelevant) information on the patient?

Authors: Marina Casini, Emanuela Midolo, Marco Marchetti

Internal reviewers: Judite Neves, Ana Bação, Vesna Kovač

The domain methodology used for this question has been collection, selection and analysis of European norms and sentences.

If additional information from prognostic testing is irrelevant to the current state of health of the patient the physician has an obligation to inform the patient and to report exactly any data of which the doctor is aware. This obligation of the physician is less strong when the patient expresses a desire not to be informed. The European normative documents relevant here are the same as those cited in the result card RC-LEG1. {1},{2},{3},{4},{5},{6}

Important
Completely
Casini M et al. Result Card LEG4 In: Casini M et al. Legal aspects In: Jefferson T, Vicari N, Raatz H [eds.]. Prognostic tests for breast cancer recurrence (uPA/PAI-1 [FEMTELLE], MammaPrint, Oncotype DX ) [Core HTA], Agenzia nationale per i servizi sanitari regionali (age.na.s), Italy ; 2013. [cited 7 February 2023]. Available from: http://corehta.info/ViewCover.aspx?id=113

References